UBS Group
NUROW

UBS Group’s NeuroMetrix, Inc. Warrants NUROW Stock Holding History

UBS Group’s Portfolio NUROW Stock Details NUROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,028
Closed – – 8701
2020
Q1 		$0 Buy
2,028
+39
+2% +$24 ﹤0.01% 8744
2019
Q4 		$0 Sell
1,989
-18
-0.9% -$3 ﹤0.01% 8646
2019
Q3 		$0 Buy
2,007
+10
+0.5% +$2 ﹤0.01% 8467
2019
Q2 		$1K Hold
1,997
– – ﹤0.01% 7787
2019
Q1 		$0 Sell
1,997
-75
-4% -$27 ﹤0.01% 8448
2018
Q4 		$0 Buy
2,072
+1,650
+391% +$545 ﹤0.01% 8496
2018
Q3 		$0 Buy
+422
New +$200 ﹤0.01% 8440
2018
Q1 		– Sell
-534
Closed – – 8364
2017
Q4 		$0 Buy
534
+391
+273% +$116 ﹤0.01% 8244
2017
Q3 		$0 Sell
143
-5
-3% -$4 ﹤0.01% 8150
2017
Q2 		$0 Buy
+148
New +$325 ﹤0.01% 8173
2016
Q4 		– Sell
-53
Closed -$1K – 8186
2016
Q3 		$1K Sell
53
-2
-4% -$24 ﹤0.01% 7566
2016
Q2 		$1K Sell
55
-1
-2% -$23 ﹤0.01% 7599
2016
Q1 		$2K Buy
56
+26
+87% +$825 ﹤0.01% 7354
2015
Q4 		$1K Buy
+30
New +$1.63K ﹤0.01% 8208

UBS Group's NUROW Position: Q2 2020 in Review

UBS Group sold out of NeuroMetrix, Inc. Warrants (NUROW) in Q2 2020, closing a stake of 2,028 shares.

UBS Group first reported a position in NUROW in Q4 2015 and held it in 14 quarters. The position peaked at $2K in Q1 2016. 0 funds tracked by Wall St. Rank hold NUROW as of Q2 2020.

  • UBS Group reported no remaining NeuroMetrix, Inc. Warrants position as of Q2 2020 after selling out during the quarter.
  • UBS Group sold 2,028 NeuroMetrix, Inc. Warrants shares in Q2 2020.
  • UBS Group first reported a position in NeuroMetrix, Inc. Warrants in Q4 2015 and held it in 14 quarters.
  • UBS Group's NeuroMetrix, Inc. Warrants position peaked at $2K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Warrants as of Q2 2020.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.